Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
Participant is over 18 years and is either not a surgical candidate or has declined surgery.
Capable and willing to provide written informed consent
Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
Disqualifiers
Participants considered unsuitable for RFA by the treating physician
Trial population
MD Anderson Cancer Center
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Questionnaire
Other interventionThis questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Health- related Quality of Life Questionnaires
This questionnaire includes twenty-four questions covering patients complaints ranging from 0 to 4. Patients will be asked about the presence and severity of each item currently on the medical appointment.
Time frame
Through study completion; an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov